Indications and uses
For the temporary relief of upper respiratory symptoms due to hay fever or airborne allergies such as: -Cough –Airway irritation –Shortness of breath
For the temporary relief of upper respiratory symptoms due to hay fever or airborne allergies such as: -Cough –Airway irritation –Shortness of breath
Take 15 minutes before meals Adults and children 12 years and older 20 drops in a little water, 2 times per day Children between 12 years and 6 years of age 10 drops in a little water, 2 times per day Children under 6 years 5 drops in a glass of water, 2 times per day
INTERFERON GAMMA 4C IMMUNE SUPPORT
INTERLEUKIN-12 4C IMMUNE SUPPORT
For the temporary relief of upper respiratory symptoms due to hay fever or airborne allergies such as: -Cough –Airway irritation –Shortness of breath
Stop use and ask doctor if symptoms of cough, shortness of breath, or wheezing do not improve, worsen or persist more than 3 days
If pregnant or breast-feeding ask a doctor before use
Keep this and all medicines out of reach of children
Take 15 minutes before meals
Adults and children 12 years and older
20 drops in a little water, 2 times per day
Children between 12 years and 6 years of age
10 drops in a little water, 2 times per day
Children under 6 years
5 drops in a glass of water, 2 times per day
Questions?: info@gunainc.com
tel. (484) 223-3500
inactive ingredient: Ethyl alcohol 30%.
take 15 minutes before meals
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d45267e3-883a-4760-85b5-ebc565c21683 | Product name | 1 | 20150910 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17089-405-18 | GAMMA -12 | 30 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 30 | 5 | |
| 17089-405-18 | GAMMA -12 | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| INTERFERON GAMMA-1B | ACTIVE INGREDIENT | 21K6M2I7AG | 2 | |
| INTERLEUKIN-12 HUMAN RECOMBINANT | ACTIVE INGREDIENT | 02FXP10O2U | 2 | |
| INTERFERON GAMMA-1B | ACTIVE MOIETY | 21K6M2I7AG | 2 | |
| INTERLEUKIN-12 HUMAN RECOMBINANT | ACTIVE MOIETY | 02FXP10O2U | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17089-405 | 17089-405-18 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| INTERFERON GAMMA-1B | 21K6M2I7AG | ACTIB |
| INTERLEUKIN-12 HUMAN RECOMBINANT | 02FXP10O2U | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GAMMA -12 | INTERLEUKIN-12 HUMAN RECOMBINANT - INTERFERON GAMMA-1B - | Guna spa | c3366fcd-7d7a-4cf8-995c-798b6d2c9ad1 | 2022-11-15 | Warnings | 17089-405-18 17089-405 17089040518 ed853c61-ca74-4c3d-e053-2995a90aecb9 c3366fcd-7d7a-4cf8-995c-798b6d2c9ad1 |
Adverse event summaries are temporarily unavailable. Other product information remains available.